Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 105
Filtrer
3.
JAMA ; 329(4): 285-286, 2023 01 24.
Article de Anglais | MEDLINE | ID: mdl-36602795

RÉSUMÉ

This Viewpoint discusses recent legal directives by the DHHS and FDA that could increase health care entities' liability for possible discriminatory biases of clinical algorithms and the need for additional legal clarity to avoid adverse effects on algorithm development and use.


Sujet(s)
Algorithmes , Prestations des soins de santé , Législation sur les dispositifs médicaux , Prejugé , Responsabilité légale , Prejugé/législation et jurisprudence , Prejugé/prévention et contrôle , États-Unis , Prestations des soins de santé/législation et jurisprudence , Prestations des soins de santé/méthodes
4.
Am J Public Health ; 111(11): 2059-2063, 2021 11.
Article de Anglais | MEDLINE | ID: mdl-34499534

RÉSUMÉ

Objectives. To examine the relationship between city-level structural stigma pertaining to sexual orientation and gender identity (SOGI) and completeness of patient SOGI data collection at US federally qualified health centers (FQHCs). Methods. We used the Human Rights Campaign's Municipal Equality Index to quantify city-level structural stigma against sexual and gender minority people in 506 US cities across 49 states. We ascertained the completeness of SOGI data collection at FQHCs from the 2018 Uniform Data System, which describes FQHC patient demographics and service utilization. We included FQHCs in cities captured by the structural stigma index in multinomial generalized linear mixed models to examine the relationship between city-level structural stigma and SOGI data completeness. Results. FQHCs in cities with more protective sexual orientation nondiscrimination policies reported more complete patient sexual orientation data (adjusted odds ratio [AOR] = 1.6; 95% confidence interval [CI] = 1.2, 2.1). This association was also found for gender identity nondiscrimination policies and gender identity data collection (AOR = 1.7; 95% CI = 1.3, 2.2). Conclusions. Municipal sexual and gender minority nondiscrimination laws are associated with social and municipal environments that facilitate patient SOGI data collection.(Am J Public Health. 2021;111(11):2059-2063. https://doi.org/10.2105/AJPH.2021.306414).


Sujet(s)
Identité de genre , Prejugé/législation et jurisprudence , Comportement sexuel , Stigmate social , Villes , Femelle , Humains , Mâle , Enquêtes et questionnaires , États-Unis
9.
NASN Sch Nurse ; 35(4): 196-197, 2020 Jul.
Article de Anglais | MEDLINE | ID: mdl-32469618

RÉSUMÉ

Annually, the National Association of School Nurses (NASN) sets advocacy goals. The goals include legislative and policy priorities. This article sets forth current NASN legislative priorities and results of advocacy that benefit students. The NASN Board of Directors are instrumental in moving policy priorities forward. In addition, this article shares NASN advocacy during the COVID-19 pandemic.


Sujet(s)
Betacoronavirus , Prejugé/législation et jurisprudence , Prejugé/prévention et contrôle , Services de santé scolaire/normes , Soins infirmiers en milieu scolaire/normes , Fumer du tabac/législation et jurisprudence , Fumer du tabac/prévention et contrôle , Adolescent , COVID-19 , Enfant , Infections à coronavirus/prévention et contrôle , Femelle , Recommandations comme sujet , Humains , Déjeuner , Mâle , Pandémies/prévention et contrôle , Pneumopathie virale/prévention et contrôle , SARS-CoV-2 , États-Unis
10.
Infez Med ; 28(1): 17-28, 2020 Mar 01.
Article de Anglais | MEDLINE | ID: mdl-32172257

RÉSUMÉ

The HIV epidemic has not yet ended, and there are ever more challenges: the recent Italian National Plan of Interventions against HIV and AIDS (Piano Nazionale di Interventi Contro HIV e AIDS (PNAIDS) 2017-2019) was hailed for its comprehensiveness. Its likelihood of success across the HIV care continuum was therefore assessed. Awareness interventions are sporadic and continue to miss high risk populations; if effectively implemented, the prescriptive detail in PNAIDS may help address this. Combined prevention needs greater focus and investment. However, there has been recent progress: free anonymous testing is available at multiple settings although improvements to provide access to key vulnerable populations are needed. Clinical management is available to a high standard across the country, with some areas for improvement in ensuring equality of access. Long-term management of people living with HIV is often effective, but discrepancies exist across regions and settings of care. It is recommended to enable implementation of PNAIDS as a matter of urgency, develop integrated awareness and testing interventions for STIs and HIV, make condoms free for high-risk populations, and develop a network of multidisciplinary services for long-term holistic care of people living with HIV.


Sujet(s)
Infections à VIH/épidémiologie , Politique de santé , Programmes nationaux de santé , Syndrome d'immunodéficience acquise/prévention et contrôle , Test de dépistage anonyme/législation et jurisprudence , Antirétroviraux/usage thérapeutique , Préservatifs masculins/ressources et distribution , Retard de diagnostic/statistiques et données numériques , Usagers de drogues/législation et jurisprudence , Infections à VIH/diagnostic , Infections à VIH/traitement médicamenteux , Infections à VIH/prévention et contrôle , Survivants à long terme d'une infection à VIH , Accessibilité des services de santé/législation et jurisprudence , Transition sanitaire , Santé holistique , Hôpitaux spécialisés , Humains , Italie/épidémiologie , Soins de longue durée/méthodes , Programmes nationaux de santé/législation et jurisprudence , Prejugé/législation et jurisprudence , Prostitution/législation et jurisprudence , Maladies sexuellement transmissibles/diagnostic , Stéréotypes , Populations vulnérables
11.
Annu Rev Public Health ; 41: 37-62, 2020 04 02.
Article de Anglais | MEDLINE | ID: mdl-31765272

RÉSUMÉ

Racism. Sexism. Heterosexism. Gender binarism. Together, they comprise intimately harmful, distinct, and entangled societal systems of self-serving domination and privilege that structure the embodiment of health inequities. Guided by the ecosocial theory of disease distribution, I synthesize key features of the specified "isms" and provide a measurement schema, informed by research from both the Global North and the Global South. Metrics discussed include (a) structural, including explicit rules and laws, nonexplicit rules and laws, and area-based or institutional nonrule measures; and (b) individual-level (exposures and internalized) measures, including explicit self-report, implicit, and experimental. Recommendations include (a) expanding the use of structural measures to extend beyond the current primary emphasis on psychosocial individual-level measures; (b) analyzing exposure in relation to both life course and historical generation; (c) developing measures of anti-isms; and (d) developing terrestrially grounded measures that can reveal links between the structural drivers of unjust isms and their toll on environmental degradation, climate change, and health inequities.


Sujet(s)
Équité en santé/organisation et administration , Prejugé/législation et jurisprudence , Prejugé/psychologie , Recherche/organisation et administration , Environnement , Identité de genre , Équité en santé/normes , Humains , Racisme , Recherche/normes , Sexisme/psychologie
13.
Am J Med Sci ; 358(5): 317-325, 2019 11.
Article de Anglais | MEDLINE | ID: mdl-31655713

RÉSUMÉ

At the end of World War II anti-Semitism was pervasive in the United States. Quotas to limit the number of Jewish students were put in place at most U.S. medical schools in the 1920s and were well-entrenched by 1945. By 1970 the quota was gone. Why? Multiple factors contributed to the end of the quota. First, attitudes toward Jews shifted as Americans recoiled from the horrors of the Holocaust and over half a million Jewish GIs returned home from World War II. Many entered the higher education system. Second, governmental and private investigations in New York City, New York State and Philadelphia exposed the quota. Third, New York State, led by Governor Thomas E. Dewey, established 4 publicly supported nondiscriminatory medical schools. These schools adsorbed many New York Jewish applicants. Fourth, from the 1920s through the 1960s some medical schools consistently or intermittently ignored the quota. Finally, the federal and several state governments passed nondiscrimination in higher education legislation. The quotas ended because of a combination of changing societal attitudes and government and private social action. This remarkable social change may be instructive as higher education now grapples with allegations of a quota system for Asian-Americans.


Sujet(s)
Enseignement médical , Juif/enseignement et éducation , Prejugé , Écoles de médecine , /enseignement et éducation , Enseignement médical/éthique , Enseignement médical/histoire , Enseignement médical/législation et jurisprudence , Histoire du 20ème siècle , Humains , Prejugé/histoire , Prejugé/législation et jurisprudence , Écoles de médecine/éthique , Écoles de médecine/législation et jurisprudence , Écoles de médecine/organisation et administration , États-Unis
15.
AMA J Ethics ; 21(6): E521-529, 2019 06 01.
Article de Anglais | MEDLINE | ID: mdl-31204993

RÉSUMÉ

Patient bias towards clinicians and employees in health care is common, but policy to address bias and to support staff is relatively limited. Creating a framework to address bias incidents is critical for cultivating environments that are safe for employees and patients. Mayo Clinic has created both policy to support staff and a reporting mechanism for accountability. Education, resources, and training are available and being disseminated to teach employees ways to respond to bias incidents.


Sujet(s)
Recommandations comme sujet , Harcèlement non sexuel/législation et jurisprudence , Politique organisationnelle , Soins aux patients/éthique , Préférence des patients/législation et jurisprudence , Prejugé/législation et jurisprudence , Gestion du risque/législation et jurisprudence , Humains
16.
Ann Intern Med ; 170(10): 717-721, 2019 05 21.
Article de Anglais | MEDLINE | ID: mdl-31060048

RÉSUMÉ

Patients and research participants have indicated that privacy of their genetic test results is an important concern, particularly with respect to insurance coverage. Internists and other physicians whose patients ask about legal protections for information generated by genome sequencing for clinical purposes can provide both reassurance and caution. Protections for medical information in general, as well as laws in some states that provide additional safeguards for genetic data, should reassure patients that this information will remain private. Patients themselves will need to weigh the risks versus the benefits of generating genomic data in deciding whether to undergo exome sequencing.


Sujet(s)
Conseil génétique/législation et jurisprudence , Confidentialité des informations génétiques/législation et jurisprudence , Dépistage génétique/législation et jurisprudence , Génomique/législation et jurisprudence , Médecine de précision , Prejugé/législation et jurisprudence , Prédisposition génétique à une maladie , Humains , États-Unis
18.
Am J Hum Genet ; 104(1): 6-7, 2019 01 03.
Article de Anglais | MEDLINE | ID: mdl-30609408

RÉSUMÉ

Protections against genetic discrimination advance genetics research and the clinical use of genetics, as well as ensure the ethical use of genetic data. Ten years after the passage of the Genetic Information Nondiscrimination Act (GINA), the American Society of Human Genetics remains a staunch advocate for GINA's strong implementation and for other laws that enhance protections for the public.


Sujet(s)
Génétique médicale/éthique , Génétique médicale/législation et jurisprudence , Santé , Prejugé/législation et jurisprudence , Prejugé/prévention et contrôle , Justice sociale/législation et jurisprudence , Confidentialité des informations génétiques/éthique , Confidentialité des informations génétiques/législation et jurisprudence , Humains , Prejugé/éthique
20.
Am Univ Law Rev ; 67(6): 1797-909, 2018.
Article de Anglais | MEDLINE | ID: mdl-30203944

RÉSUMÉ

This Article addresses the impact of school voucher programs on students with disabilities. We show that for children with disabilities, the price of admission into so-called "school choice" programs is so high that it is effectively no real choice at all. School voucher programs require students with disabilities to sign away their robust federal rights and protections in the public school system. Under the Individuals with Disabilities Education Act (IDEA)--the preeminent legislative safeguard for students with disabilities--these rights include the right to a "free and appropriate public education" delivered through an "individualized education plan." By giving up these protections, children with disabilities are left at the mercy of private schools that have no legal obligation to provide them with an appropriate education, and, in the vast majority of cases, are not legally prohibited from discriminating against them on the basis of their disability. We argue that school voucher programs--including a proposed federal voucher program--put the education of students with disabilities back decades, and likely constitute a violation of the Equal Protection Clause of the U.S. Constitution.


Sujet(s)
Enfants handicapés/enseignement et éducation , Enfants handicapés/législation et jurisprudence , Enseignement spécialisé/législation et jurisprudence , Éducation/législation et jurisprudence , Établissements scolaires/législation et jurisprudence , Adolescent , Enfant , Enfant d'âge préscolaire , Comportement de choix , Droits civiques/enseignement et éducation , Droits civiques/législation et jurisprudence , Éducation/économie , Enseignement spécialisé/histoire , Histoire du 20ème siècle , Humains , Indiana , Prejugé/législation et jurisprudence , Secteur privé , Secteur public , Décisions de la Cour Suprême (USA) , États-Unis
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...